Диссертация (1140625), страница 20
Текст из файла (страница 20)
Y. Kutbi [et al.] // BMCInfect. Dis. – 2015. – Vol. 15. P. 569.100. Averbach, S. H. Mycoplasma genitalium and preterm delivery at an urbancommunity health center/ S. H. Averbach, M. R. Hacker, T. Yiu [et al.] // Int. J.Gynaecol. Obstet. – 2013.
– Vol. 123. - P.54–57.101. Associations between early first sexual intercourse and later sexual andreproductive outcomes: a systematic review of population-based data / W. Heywood [etal.] // Archives of sexual behavior. - 2015. - Vol. 44 (3). - P. 531–569.102. Bacterial load in daily urine samples of patients infected with Mycoplasmagenitalium, mutation analysis, and response to treatment [Electronic resource] / M.Gosse, S. Nordbo, B. Pukstad// Infectious Diseases in Obstetrics and Gynecology.
–2016. – URL: ttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088277/pdf/IDOG20168382469.pdf (date of the application 24.11.2017).103. Baczynska, A. Morphology of human fallopian tubes after infection withMycoplasma genitalium and Mycoplasma hominis - in vitro organ culture study / A.Baczynska, P. Funch, J. Fedder // Hum. Reprod. - 2007. – Vol. 22.
– P. 968–979.104. Birger, R. Should we screen for the sexually-transmitted infectionMycoplasma genitalium? Evidence synthesis using a transmission-dynamic model / R.Birger, J. Saunders, C. Estcourt [et al.] // Sci Rep. – 2017. - Vol. 23. - № 1. – P. 161168.105. Bissessor, M. Macrolide resistance and azithromycin failure in aMycoplasma genitalium-infected cohort and response of azithromycin failures toalternative antibiotic regimens / M. Bissessor, S.N Tabrizi., J. Twin [et al.] // Clin.Infect.
Dis. - 2015. - Vol.60. - №8. – P.1228-1236.106. Bjartling, C. Mycoplasma genitalium in cervicitis and pelvic inflammatorydisease among women at a gynecologic outpatient service / C. Bjartling, S. Osser, K .Persson // Am. J. Obstet. Gynecol. - 2012. – Vol. 206. - № 6. – P. 476–484.107. Brotman, R. M. Bacterial vaginosis assessed by gram stain and diminishedcolonization resistance to incident gonococcal, chlamydial, and trichomonal genital118infection / R. M. Brotman, M. A. Klebanoff, T.
R. Nansel [et al.] // J. Infect. Dis. 2010. - Vol. 202. – P.1907–1915.108. Braam, J.F. Multidrug-resistant Mycoplasma genitalium infections inEurope / J.F.Braam, L. van Dommelen, C.J. Henquet [et al.] // Eur. J. Clin. Microbiol.Infect. Dis. – 2017. – Vol.6. - № 9. - P.1565-1567.109. Bradshaw, C. S. Persistence of Mycoplasma genitalium followingazithromycin therapy / C.S.
Bradshaw, M.Y. Chen, C.K. Fairley // PLoS ONE. - 2008. Vol. 3. - № 11. - P. 3618.110. Campos, G. Prevalence of Mycoplasma genitalium and Mycoplasmahominis in urogenital tract of Brazilian women / G. Campos, T. Lobao, N. Selis [et al.]// BMC Infect. Dis. – 2015. – Vol.15. – P. 2-8.111. Cazanave, C.
Mycoplasma genitalium, an emerging sexually transmittedpathogen / C. Cazanave, L. Manhart, C. Bebear // Med. Mal. Infect. - 2012. – Vol. 42. –P. 381-392.112. Carlsen, K. Mycoplasma genitalium PCR: does freezing of specimensaffect sensitivity? / K. Carlsen, J. Jensen // J. Clin. Microbiol. – 2010. - Vol. 48. - №10.– P. 3624-3627.113. Chrisment, D. Detection of macrolide resistance in Mycoplasma genitaliumin France / D. Chrisment, A.
Charron, C. Cazanave [et al.] // Jour. Antimicrob.Chemother. – 2012. – Vol. 67. - №11. – P. 2598-2601.114. Cox, C. Mycoplasma hominis and Gardnerella vaginalis display asignificant synergistic relationship in bacterial vaginosis / C. Cox, A. P. Watt, J. P.McKenna [et al.] // Eur. J. Clin. Microbiol. Infect. Dis. – 2016. - Vol. 35 - №3. – P.481-487.115. Daley, G. M. Mycoplasma genitalium: a review [Electronic resource] / G.M. Daley, D. B. Russell, S.
N. Tabrizi // International Journal of STD and AIDS. –2014. – URL: http://std.sagepub.com/content/early/2013/12/16/0956462413515196(date of the application 23.11.2017).116. Das, K. Mycoplasma genitalium promotes epithelial crossing andperipheral blood mononuclear cell infection by HIV-1 / K. Das, G. De la Garza, E.119Siwak [et al.] // International Journal of Infectious Diseases. – 2014. – Vol.
23. - P.31–38.117. Dehon, P. M. Histological evidence of chronic Mycoplasma genitaliuminduced cervicitis in HIV-infected women: а retrospective cohort study / P. M. Dehon,M. E. Hagensee, K. J. Sutton [et al.] // J. Infect. Dis. – 2016. – Vol. 213. - P. 1828–1835.118. Dehon, P. M. Mycoplasma genitalium infection is associated withmicroscopic signs of cervical inflammation in liquid cytology specimens / P. M. Dehon,C. L. McGowin // J. Clin.
Microbiol. – 2014. – Vol. 52. – P. 2398–2405.119. Dehon, P. M. The immunopathogenesis of Mycoplasma genitaliuminfections in women: a narrative review / P. M. Dehon, C. L. McGowin // Sex. Transm.Dis. - 2017. – Vol. 44. - № 7. – P. 428-432.120. Di Paola, M. Characterization of cervico-vaginal microbiota in womendeveloping persistent high-risk human papillomavirus infection / M. Di Paola, C. Sani,A. Clemente // Sci Rep. – 2017. - Vol.7. -№1.
– P.100 - 106.121. Edouard, S. Mycoplasma genitalium, an agent of reemerging sexuallytransmitted infections / S. Edouard, H. Tissot-Dupont, G. Dubourg [et al.] // APMIS –2017. - Vol. 125. - № 10. – P. 916-920.122. Esber, A. Risk of bacterial vaginosis among women with herpes simplexvirus type 2 infection: a systematic review and meta-analysis / A. Esber, R. VicettiMiguel [et al.] // J.
Infect. Dis. – 2015. - Vol. 212. - №1. – P. 8-17.123. Falk, L. Time to eradication of Mycoplasma genitalium after antibiotictreatment in men and women / L. Falk, M. Enger, J. S. Jensen // J. Antimicrob.Chemother. – 2015. Vol. 70. - № 11. - P. 3134–3140.124. Filardo, S. Diversity of сervical microbiota in asymptomatic Chlamydiatrachomatis genital infection: a pilot study / S.
Filardo, M. Di Pietro [et al.] // Front.Cell Infect. Microbiol. – 2017. – Vol. 7. – P. 1- 8.125. Francis, S. Prevalence of rectal Trichomonas vaginalis and Mycoplasmagenitalium in male patients at the San Francisco STD clinic, 2005–2006 / S. Francis, C.Kent, J. Klausner // Sex. Transm. Dis. – 2008. - Vol. 35. - №9. – P. 797-800.120126. Gaydos, C. Mycoplasma genitalium as a contributor to the multipleetiologies of cervicitis in women attending sexually transmitted disease clinics / C.Gaydos, N. Maldeis, A.
Hardick // Sex. Transm. Dis. – 2009. – Vol. 36. - № 10. – P.598-606.127. Gesink, D. С. Mycoplasma genitalium in Toronto, Ont: estimates ofprevalence and macrolide resistance / D. С. Gesink, C.S. Racey, C. Seah // Can. Fam.Physician. – 2016. – Vol.62. - № 2. – P.96-101.128. Gesink, D. C. Mycoplasma genitalium presence, resistance andepidemiology in Greenland / D. C. Gesink, G. Mulvad, R. Montgomery-Andersen [etal.] // Int. J. Circumpolar. Health. 2012. – Vol. 71.
- P.1–8.129. Getman, D. Mycoplasma genitalium prevalence, coinfection, and macrolideantibiotic resistance frequency in a multicenter clinical study cohort in the united states /D. Getman, A. Jiang, M. O'Donnell // J. Clin. Microbiol. – 2016. - Vol. 54.
— №9. - P.2278 - 2283.130. Gomih-Alakija, A. Clinical characteristics associated with Mycoplasmagenitalium among female sex workers in Nairobi, Kenya / A. Gomih-Alakija, J. Ting,N. [et al.] // Mugo Journal of Clinical Microbiology. – 2014. – Vol. 52. - № 10. - P.3660–3666.131. Gratrix, J. Prevalence and antibiotic resistance of Mycoplasma genitaliumamong STI clinic attendees in Western Canada: a cross-sectional analysis / J.
Gratrix, S.Plitt, L. Turnbull [et al.] // BMJ - 2017. – Vol. 7. - № 7.- P. 163.132. Grzesko, J. Occurrence of Mycoplasma genitalium in fertile and infertilewomen / J. Grzesko, M. Elias, B. Maczynska // Fertil. Steril. – 2009. - Vol. 91. - P.2376–2380.133.
Guschin, A. Treatment efficacy, treatment failures and selection ofmacrolide resistance in patients with high load of Mycoplasma genitalium duringtreatment of male urethritis with josamycin / A. Guschin, P. Ryzhikh, T. Rumyantseva// BMC Infectious Diseases. – 2015. – Vol. 15. – Article 40.134. Haggerty, C.L. Failure of cefoxitin and doxycycline to eradicateendometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic121inflammatory disease / C.L. Haggerty, P.A. Totten, S.G. Astete [et al] // Sex. Transm.Infect.
– 2008. - Vol. 84. - P.338–342.135. Hancock, E. B. Comprehensive assessment of sociodemographic andbehavioral risk factors for Mycoplasma genitalium infection in women / E. B. Hancock,L.E. Manhart, S. J. Nelson et al] // Sex. Transm. Dis. – 2010. - Vol. 37. - № 12.- P. 777783.136. Hitti, J. Correlates of cervical Mycoplasma genitalium and risk of pretermbirth among Peruvian women / J. Hitti, P. Garcia, P.
Totten [et al] // Sex. Transm. Dis.- 2010. – Vol. 37. - P. 81–85.137. Horner, P. Association of Mycoplasma genitalium with balanoposthitis inmen with non-gonococcal urethritis / P. Horner, D. Taylor-Robinson // Sex. Transm.Infect. – 2011. - Vol. 87. - № 1.- P. 38-40.138. Horner, P. Mycoplasma genitalium Infection in Men [Electronic resource] /P.Horner,D.Martin//J.Infect.Dis.–2017.-URL:https://www.ncbi.nlm.nih.gov/pubmed/28838074 (date of the application 12.09.2017).139.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
